127 related articles for article (PubMed ID: 16732963)
21. [Study of Th cell subsets in bone marrow of myelodysplastic syndromes patients].
Wang XL; Shao ZH; Yao C; He GS; Liu H; Shi J; Bai J; Cao YR; Tu MF; Wang HQ; Xing LM; Sun J; Jia HR; Yang CL
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):743-5. PubMed ID: 16620580
[TBL] [Abstract][Full Text] [Related]
22. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation.
Nishikata I; Nakahata S; Saito Y; Kaneda K; Ichihara E; Yamakawa N; Morishita K
Oncogene; 2011 Oct; 30(40):4194-207. PubMed ID: 21516122
[TBL] [Abstract][Full Text] [Related]
23. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the characteristics of folate binding proteins and its relationship with expression of multidrug resistance P-glycoprotein in myelodysplastic syndromes.
Chen J; Li R; Yan S; Li Q; Bai T; Wang S
Chin Med J (Engl); 1998 Mar; 111(3):235-8. PubMed ID: 10374424
[TBL] [Abstract][Full Text] [Related]
25. Chronic myelomonocytic leukemia with t(1;3)(p36;q21) and a synchronous gastric cancer.
Fujisawa S; Harano H; Yamazaki E; Motomura S; Mohri H; Ishigatsubo Y
Am J Med Sci; 2000 Apr; 319(4):258-60. PubMed ID: 10768613
[TBL] [Abstract][Full Text] [Related]
26. Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: report of 2 new cases.
Millington K; Hudnall SD; Northup J; Panova N; Velagaleti G
Exp Mol Pathol; 2008 Apr; 84(2):189-93. PubMed ID: 18339374
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
28. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).
Shimizu S; Suzukawa K; Kodera T; Nagasawa T; Abe T; Taniwaki M; Yagasaki F; Tanaka H; Fujisawa S; Johansson B; Ahlgren T; Yokota J; Morishita K
Genes Chromosomes Cancer; 2000 Mar; 27(3):229-38. PubMed ID: 10679911
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis.
Welborn JL; Lewis JP; Jenks H; Walling P
Cancer Genet Cytogenet; 1987 Oct; 28(2):277-85. PubMed ID: 3476187
[TBL] [Abstract][Full Text] [Related]
30. Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.
Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G
Cancer Genet Cytogenet; 2010 Jan; 196(1):89-92. PubMed ID: 19963141
[TBL] [Abstract][Full Text] [Related]
31. A novel t(1;12)(q21;q24) in a patient with myelodysplastic syndrome.
Park TS; Lee SG; Song J; Kim JS; Choi JR
Ann Hematol; 2010 May; 89(5):513-6. PubMed ID: 19697027
[No Abstract] [Full Text] [Related]
32. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.
Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q
Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444
[TBL] [Abstract][Full Text] [Related]
33. A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.
Coccaro N; Brunetti C; Tota G; Pierri CL; Anelli L; Zagaria A; Casieri P; Impera L; Minervini CF; Minervini A; Cumbo C; Ricco A; Carluccio P; Orsini P; Specchia G; Albano F
Leuk Lymphoma; 2018 Apr; 59(4):996-999. PubMed ID: 28718702
[No Abstract] [Full Text] [Related]
34. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
[TBL] [Abstract][Full Text] [Related]
35. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
36. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
37. Translocation t(1;3)(p36;q21) in malignant myeloid stem cell disorders.
Cambrin GR; Mecucci C; Van Orshoven A; Tricot G; Van den Berghe H
Cancer Genet Cytogenet; 1986 May; 22(1):75-81. PubMed ID: 3955532
[TBL] [Abstract][Full Text] [Related]
38. Donor-cell MDS in a 12-year-old girl 3 years after allogeneic hematopoietic SCT for MDS, both with a t(3;3)(q21;q26) cytogenetic aberration.
Leguit RJ; van den Berg H; Buijs A; Mellink C; Bierings M
Bone Marrow Transplant; 2011 Jun; 46(6):908-10. PubMed ID: 20838388
[No Abstract] [Full Text] [Related]
39. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
40. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.
Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; García M; Solé F; Ariza A; Serrano S
Hum Pathol; 2006 Jul; 37(7):867-73. PubMed ID: 16784987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
